← Back to Search

Other

LEO 152020 tablet for Atopic Dermatitis

Phase 2
Waitlist Available
Research Sponsored by LEO Pharma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Are you at least 18 years old?
Have you had atopic dermatitis for at least a year?
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0 to week 16+3 days
Awards & highlights

Study Summary

This trial is testing a new tablet to see if it works to treat atopic dermatitis and what the side effects are when compared with a placebo tablet. There will be a 16-week treatment period during which participants will take the tablets and visit the clinic for tests and evaluations.

Eligible Conditions
  • Atopic Dermatitis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You must be 18 or older to participate.
Select...
You have had eczema for at least one year.
Select...
You have moderate to severe atopic dermatitis, as diagnosed by a doctor.
Select...
Is your eczema present on at least 5% of your body? To help you understand, imagine that the palm of your hand is about 1% of your body surface area. So, is your eczema covering an area that's about the size of 5 hands?
Select...
Have you used a cream containing corticosteroids to treat your skin condition in the last 6 months, but it did not help improve your condition?
Select...
You haven't already tried at least three different types of treatments (like pills or injections) for your AD.
Select...
Have you ever had an irregular heartbeat?
Select...
You are not currently involved in another study testing a new treatment.
Select...
You are not currently pregnant or nursing a baby.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0 to week 16+3 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0 to week 16+3 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in EASI from baseline to Week 16
Secondary outcome measures
Number of adverse events from baseline to Week 16+3 days per subject

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: LEO 152020 tablet - Dose regimen 3Experimental Treatment1 Intervention
Participants will be asked to take tablets from Week 0 to Week 16 (end of treatment).
Group II: LEO 152020 tablet - Dose regimen 2Experimental Treatment1 Intervention
Participants will be asked to take tablets from Week 0 to Week 16 (end of treatment).
Group III: LEO 152020 tablet - Dose regimen 1Experimental Treatment1 Intervention
Participants will be asked to take tablets from Week 0 to Week 16 (end of treatment).
Group IV: LEO 152020 placebo tabletPlacebo Group1 Intervention
Participants will be asked to take tablets from Week 0 to Week 16 (end of treatment).

Find a Location

Who is running the clinical trial?

LEO PharmaLead Sponsor
268 Previous Clinical Trials
188,235 Total Patients Enrolled
Medical ExpertStudy DirectorLEO Pharma
53 Previous Clinical Trials
9,885 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the LEO 152020 pill been cleared by the FDA?

"LEO 152020 tablet is currently in Phase 2 of clinical trials. This means that while there is data supporting safety, there is no evidence yet of efficacy."

Answered by AI

Where are patients able to enroll in this trial?

"This study is recruiting patients at 10 sites. The sites are located in Beverly Hills, Los Angeles and Saint-Jérome as well as 7 other locations. It is important to select the site closest you to minimize travel requirements if you enroll."

Answered by AI

How many individuals are included in this research project?

"Clinicaltrials.gov indicates that this trial is ongoing and presently looking for eligible participants. The study was originally posted on December 13th, 2021 and last updated on September 30th, 2022. A total of 224 individuals are needed at 10 sites nationwide."

Answered by AI

Are there any places left for people in this experiment?

"Yes, the trial is still recruiting patients. The clinicaltrials.gov listing provides the date that the study was posted (12/13/2021) as well as when it was last updated (9/30/2022). This research is looking for 224 individuals across 10 different sites."

Answered by AI

Who else is applying?

What state do they live in?
Tennessee
Texas
Other
California
What site did they apply to?
Other
Leo Pharma Investigational Site
LEO Pharma Investigational Site
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1
2
3+
0

Why did patients apply to this trial?

To help the the medical research and for money compensation. To learn more about the condition and looking for help in improving it.
PatientReceived 1 prior treatment
For absolutely no reason I start itching there’s nothing there and I itchy to the point the skin comes off and I’m not bleeding. Doctor says it’s topical dermatologist but doesn’t know what to do with it or there’s nothing to do with it no answers.
PatientReceived no prior treatments

What questions have other patients asked about this trial?

Is the trial compensated and gas mileage paid? How far will I have to travel? HOW long is the study scheduled to rib?
PatientReceived 2+ prior treatments
How long ? What is involved? Repeat visits? For how long? What does it pay?
PatientReceived 2+ prior treatments

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. LEO Pharma Investigational Site: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis
2021. "Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05117060.
~65 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top